FDA Drug recall D-0884-2022
Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, N…
- FDA Drug
- Class II
- completed
- Published 2022-05-25
On 2022-05-25 the FDA classified a Class II recall of Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, N… by Cardinal Health, citing TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0884-2022 |
| Classification | Class II |
| Status | completed |
| Initiated | 2022-04-05 |
| Published | 2022-05-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Cardinal Health |
| Distribution | NM |
Product
Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80
Reason
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
Identifiers
| ndc | 0002-1433-01 |
|---|---|
| ndc | 0002-1433-80 |
| ndc | 0002-1433-61 |
| ndc | 0002-1434-01 |
| ndc | 0002-1434-80 |
| ndc | 0002-1434-61 |
| ndc | 0002-2236-01 |
| ndc | 0002-2236-80 |
| ndc | 0002-2236-61 |
| ndc | 0002-3182-01 |
| ndc | 0002-3182-80 |
| ndc | 0002-3182-61 |
| code_info | Lot #: D484557A, Exp: 10/25/2023. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0884-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.